Well, while you may have a point, today's "fledgling biotech" is tomorrow's next Gilead. If all goes as it has thus far in terms of results and safety, there is no reason that CYDY couldn't be the next Gilead if it wanted to. Yes, we have just one molecule right now, with dozens of indications, but if CYDY really started making money, they could expand into other things, if they so desired.

Of course NP will be on his private island by that time, and we'll all have great photos from our group Vegas trip.